Speranza Therapeutics announces value-based program for opioid detox facilities program vows to reduce costly facility against Medical Advice (AMA) leave rates
August 4, 2021
August 4, 2021
June 10, 2021
March 23, 2021
January 6, 2021
December 17, 2020
December 15, 2020
September 17, 2020
September 17, 2020
June 16, 2020
November 19, 2024
Sakura Finetek Europe and MEDIPATH, a group of independent French pathologists, announced their collaboration to enhance cancer diagnostics and thus c...
November 18, 2024
Antibodies and conjugates to illuminate your research Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life s...
November 14, 2024
Azenta, Inc. (Nasdaq: AZTA) today announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes the...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225